Historical record - last NADAC effective date: 2/21/2018

Product Information

ZYCLARA 3.75% CREAM PUMP is a brand product labeled by Bausch Health US LLC, priced at $158.1732 per GM under NDC 99207027175. Its NADAC has been published 273 times since Nov 28, 2013.

FDA first approved this application on Mar 25, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ZYCLARA 3.75% CREAM PUMP

imiquimod
$158.1732per GM

Strength

37.5 mg/g

NDC

99207027175

Classification

Brand

Dosage Form

CREAM

Route

TOPICAL

Effective Date

2/21/2018

Active Ingredients

IMIQUIMOD

Approval Type

New Drug (NDA)

FDA Application

NDA022483

FDA Approved

3/25/2010

TE Code

AB

On Market Since

1/1/2012

Pharmacological Classes

Increased Cytokine Activity
Increased Cytokine Production
Interferon Inducers

Price Statistics

The NADAC for ZYCLARA 3.75% CREAM PUMP has been published 273 times since Nov 28, 2013, and over the history we have for it it has risen 53.9%. The table below summarizes its recorded NADAC range and movement.

Current price$158.1732 per GM
All-time high$159.0134 (Feb 14, 2018)
All-time low$100.5593 (Dec 18, 2013)
Median price$135.1528
Average price$136.7047
Largest weekly change+15.0% (Jan 15, 2014)
Weeks tracked273
Tracking sinceNov 28, 2013

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

N/A

3Y

N/A

5Y

N/A

All

+53.9%

Last surveyed Feb 13, 2019 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 85% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of ZYCLARA 3.75% CREAM PUMP?

The current National Average Drug Acquisition Cost (NADAC) for ZYCLARA 3.75% CREAM PUMP, manufactured by Bausch Health US LLC, is $158.1732 per GM (NDC 99207027175), effective Feb 13, 2019.

How has the price of ZYCLARA 3.75% CREAM PUMP changed over time?

Over the history we have for it, the NADAC for ZYCLARA 3.75% CREAM PUMP has risen 53.9%. It has been tracked across 273 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for ZYCLARA 3.75% CREAM PUMP?

Since Nov 28, 2013, the NADAC for ZYCLARA 3.75% CREAM PUMP has ranged from a low of $100.5593 (Dec 18, 2013) to a high of $159.0134 (Feb 14, 2018), with a median of $135.1528 per GM.

Are there cheaper alternatives to ZYCLARA 3.75% CREAM PUMP?

Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IMIQUIMOD 3.75% CREAM PUMP, is $24.3913 per GM — about 85% below ZYCLARA 3.75% CREAM PUMP.

Who manufactures ZYCLARA 3.75% CREAM PUMP?

ZYCLARA 3.75% CREAM PUMP (NDC 99207027175) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.